COVID-19 Prevention
AstraZeneca to Supply Canada with 100,000 Doses of Evusheld, a Long-Acting Antibody Combination for the Prevention of COVID-19
AstraZeneca Canada
PR-M02-22-21Feb 23, 2022
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05Feb 08, 2022
Cleanrooms
Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned
Grant Merrill; Jose Jimenez
AES Clean Technology Inc.
PAO-06-21-CL-06Jun 18, 2021
COVID-19 Therapeutics
Tevogen Bio Announces Partnership With BioCentriq to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19
Tevogen Bio
PR-M03-21-002Mar 15, 2021
COVID-19 Therapeutics
How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic
Jonathan C. Javitt, M.D., M.P.H.
NeuroRx
PAP-Q4-20-CL-017Dec 09, 2020
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
Theresa Deisher, Ph.D.
AVM Biotechnology
PAP-Q4-20-CL-005Dec 09, 2020